Intercytex Group acquires Axordia - MarketLine Financial Deals

Intercytex Group acquires Axordia

Intercytex Group acquires Axordia - MarketLine Financial Deals
Intercytex Group acquires Axordia
Published Dec 22, 2008
3 pages — Published Dec 22, 2008
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Intercytex Group plc, a regenerative medicine company, has acquired Axordia Limited, a developer of stem cell therapies, for GBP1.68 million.

  
Source:
Document ID
MA00998_081223
Country
Ticker
FIP=GB
Ticker
ICX=GB
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Intercytex Group acquires Axordia" Dec 22, 2008. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Intercytex-Group-acquires-Axordia-2052-933>
  
APA:
MarketLine Financial Deals. (2008). Intercytex Group acquires Axordia Dec 22, 2008. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Intercytex-Group-acquires-Axordia-2052-933>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.